TLCR Reading Tools
How to cite item
Promising benefits of MET inhibition combined with EGFR/ALK tyrosine kinase inhibitor in heavily treated non-small cell lung cancer patients with
EGFR
-mutant/
ALK
rearrangement and MET overexpression: a retrospective cohort study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{120342}, author = {Zhou, Q., Qiu, J., Yue, H., Xu, D., Meng, S.}, title = {Promising benefits of MET inhibition combined with EGFR/ALK tyrosine kinase inhibitor in heavily treated non-small cell lung cancer patients with <em>EGFR</em>-mutant/<em>ALK</em> rearrangement and MET overexpression: a retrospective cohort study}, journal = {Translational Lung Cancer Research}, volume = {15}, number = {7}, year = {2026}, url = {https://tlcr.amegroups.org/article/view/120342} }